Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Protara Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +4 vs. Q4 2023
- Shares held
- 4.57M
- +212.5K (+4.9%) vs. Q4 2023
- Total value
- $18.3M
- +$10.2M (+124.6%) vs. Q4 2023
- New holders
- 7
- 8 more added
- Sold out
- 3
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 2 | $8 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 22 | $88 | 0.00% | +6+37.5% | Added |
| Advisor Group Holdings, Inc. | 100 | $401 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 570 | $2.29K | 0.00% | +1+0.2% | Added |
| ADAR1 Capital Management, LLC | 2,000 | $8.02K | 0.00% | −194−8.8% | Reduced |
| Tower Research Capital LLC (TRC) | 2,580 | $10.3K | 0.00% | −1,758−40.5% | Reduced |
| UBS Group AG | 3,725 | $14.9K | 0.00% | +2,809+306.7% | Added |
| Royal Bank of Canada | 3,986 | $16.0K | 0.00% | +3,258+447.5% | Added |
| Acadian Asset Management LLC | 6,314 | $25.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 10,000 | $40.1K | 0.00% | +10,000 | New |
| Susquehanna International Group, LLP | 11,185 | $44.9K | 0.00% | +11,185 | New |
| Dimensional Fund Advisors LP | 12,126 | $48.6K | 0.00% | +12,126 | New |
| Two Sigma Securities, LLC | 17,393 | $69.7K | 0.00% | +17,393 | New |
| Northern Trust Corp | 17,591 | $70.5K | 0.00% | −536−3.0% | Reduced |
| Simplex Trading, LLC | 17,850 | $71.0K | 0.00% | +17,850 | New |
| Bank of New York Mellon Corp | 17,907 | $71.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 19,748 | $79.2K | 0.00% | −5,397−21.5% | Reduced |
| Truist Financial Corp | 20,000 | $80.2K | 0.00% | +20,000 | New |
| Boothbay Fund Management, LLC | 22,647 | $90.8K | 0.00% | +3,783+20.1% | Added |
| Citadel Advisors LLC | 25,948 | $104.1K | 0.00% | −12,087−31.8% | Reduced |
| State Street Corp | 26,600 | $106.7K | 0.00% | −4,300−13.9% | Reduced |
| Two Sigma Advisers, LP | 27,018 | $108.3K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 28,000 | $112.3K | 0.00% | +16,000+133.3% | Added |
| BlackRock Inc. | 30,864 | $123.8K | 0.00% | −3,452−10.1% | Reduced |
| Bridgeway Capital Management, LLC | 59,000 | $236.6K | 0.00% | −5,000−7.8% | Reduced |
| Geode Capital Management, LLC | 82,907 | $332.5K | 0.00% | +4,389+5.6% | Added |
| Renaissance Technologies LLC | 84,600 | $339.0K | 0.00% | −28,700−25.3% | Reduced |
| Privium Fund Management (UK) Ltd | 119,730 | $495.7K | 0.25% | 00.0% | Unchanged |
| StemPoint Capital LP | 168,442 | $675.5K | 0.18% | +168,442 | New |
| Baker Bros. Advisors LP | 199,671 | $800.7K | 0.01% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 202,701 | $812.8K | 0.22% | +14,037+7.4% | Added |
| Boxer Capital, LLC | 209,227 | $839.0K | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 427,612 | $1.71M | 0.00% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,692,594 | $10.8M | 2.35% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −15,831−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,506−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −6−100.0% | Sold out |